Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNG2 | P59768 | 1/20 | 0.74 |
| ▸ | GNB1 | P62873 | 1/20 | 0.74 |
| ▸ | MEN1 | O00255 | 5/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.67 |
| ▸ | RECQL | P46063 | 2/20 | 0.67 |
| ▸ | BLM | P54132 | 2/20 | 0.67 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.67 |
| ▸ | USP2 | O75604 | 2/20 | 0.67 |
| ▸ | THRB | P10828 | 1/20 | 0.67 |
| ▸ | CDK2 | P24941 | 1/20 | 0.67 |
| ▸ | CHAT | P28329 | 1/20 | 0.67 |
| ▸ | BLVRB | P30043 | 1/20 | 0.67 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 6/20 | 0.55 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.55 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29379080 | 1.00 | GNG2 (0.74) | GNG2GNB1MEN1KMT2ATDP1 | |
| SCHEMBL3182620 | 0.99 | GNG2 (0.72) | GNG2GNB1MEN1KMT2ATDP1 | |
| SCHEMBL3182615 | 0.99 | GNG2 (0.72) | GNG2GNB1MEN1KMT2ATDP1 | |
| SCHEMBL30160637 | 0.90 | MEN1 (0.86) | GNG2GNB1MEN1KMT2ATDP1 | |
| SCHEMBL3625922 | 0.90 | MEN1 (0.86) | GNG2GNB1MEN1KMT2ATDP1 | |
| SCHEMBL20907331 | 0.88 | FTO (0.73) | GNG2GNB1MEN1KMT2ATDP1 | |
| SCHEMBL5364186 | 0.87 | MEN1 (0.62) | GNG2GNB1MEN1KMT2ATDP1 | |
| SCHEMBL30408346 | 0.85 | GNG2 (1.00) | GNG2GNB1MEN1KMT2ATDP1 | |
| SCHEMBL29942282 | 0.85 | GNG2 (1.00) | GNG2GNB1MEN1KMT2ATDP1 | |
| SCHEMBL29424349 | 0.85 | GNG2 (1.00) | GNG2GNB1MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 392 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| US-20230310285-A1 | DEVELOPER COMPOSITION COMPRISING DIRECT DYE | L'OREAL (FR) | 2023-10-05 | — | — | US | claimed |
| WO-2023192788-A1 | DEVELOPER COMPOSITION COMPRISING DIRECT DYE | L'OREAL (FR) | 2023-10-05 | — | — | WO | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| US-7842826-B2 | Process for synthesizing halogenated derivatives of fluorescein for use in the production of non-volatile memory devices | STMICROELECTRONICS S.R.L. (IT) | 2010-11-30 | — | — | US | claimed |
| US-20080061289-A1 | PROCESS FOR SYNTHESIZING HALOGENATED DERIVATIVES OF FLUORESCEIN FOR USE IN THE PRODUCTION OF NON-VOLATILE MEMORY DEVICES | STMICROELECTRONICS S.R.L. (IT) | 2008-03-13 | — | — | US | claimed |
| US-20030108488-A1 | Compositions and methods to inhibit tartar and microbes using denture adhesive compositions with colorants | PROCTER & GAMBLE COMPANY, THE | 2003-06-12 | — | — | US | claimed |
| US-20260048025-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | NATURAL EXTRACTION SYS LLC (US) | 2026-02-19 | — | — | US | disclosed |
| US-12496344-B2 | Biophotonic materials and uses thereof | FLE INT S R L (IT) | 2025-12-16 | — | — | US | disclosed |
| US-12377068-B2 | In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors | PROVECTUS PHARMATECH, INC. (US) | 2025-08-05 | — | — | US | disclosed |
| US-12281180-B2 | Peptoid-peptide macrocycles, pharmaceutical compositions and methods of using the same | NEW YORK UNIVERSITY (US) | 2025-04-22 | — | — | US | disclosed |
| US-20250108658-A1 | INKJET PRINTING PROCESSES FOR TEMPORARY TATTOOS | Prism Inks, Inc. (US) | 2025-04-03 | — | — | US | disclosed |
| US-12133840-B2 | Halogenated xanthene composition and method for treating hematologic cancers | PROVECTUS PHARMATECH, INC. (US) | 2024-11-05 | — | — | US | disclosed |
| EP-0261934-A2 | Rapid differentiation of bacteria using cyclic polypeptide antibiotics | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1988-03-30 | — | — | EP | disclosed |
| EP-0261933-A2 | Rapid differentiation of bacteria using polyether antibiotics | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1988-03-30 | — | — | EP | disclosed |
| EP-0259133-A2 | Use of organic buffers to reduce dehydroascorbic acid interference in analytical methods | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1988-03-09 | — | — | EP | disclosed |
| EP-0247848-A2 | Water-compatible reducible compounds and their use in analytical compositions and methods | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1987-12-02 | — | — | EP | disclosed |
| EP-0211898-A1 | REDUCIBLE COMPOUNDS AND ANALYTICAL COMPOSITIONS, ELEMENTS AND ME THODS UTILIZING SAME. | EASTMAN KODAK CO (US) | 1987-03-04 | — | — | EP | disclosed |
| WO-1986004681-A1 | REDUCIBLE COMPOUNDS AND ANALYTICAL COMPOSITIONS, ELEMENTS AND ME THODS UTILIZING SAME | EASTMAN KODAK COMPANY (US) | 1986-08-14 | — | — | WO | disclosed |
| EP-0190740-A2 | Use of substituted quinone electron transfer agents in analytical determinations | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1986-08-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080061289-A1 | PROCESS FOR SYNTHESIZING HALOGENATED DERIVATIVES OF FLUORESCEIN FOR USE IN THE PRODUCTION OF NON-VOLATILE MEMORY DEVICES | FASTKD5, KCNA5, KCNQ5 | GNG2 3802/4885GNB1 3231/4885MEN1 2830/4885 |
| US-12377068-B2 | In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors | RNASE1, XDH, TYR | GNG2 2633/4885GNB1 1488/4885MEN1 740/4885 |
| US-12133840-B2 | Halogenated xanthene composition and method for treating hematologic cancers | ETV6, BCL6, XPA | GNG2 1002/4885GNB1 694/4885MEN1 473/4885 |
| US-20030108488-A1 | Compositions and methods to inhibit tartar and microbes using denture adhesive compositions with colorants | TAS2R10, TAS1R1, TAS2R40 | GNG2 2360/4885GNB1 2782/4885MEN1 4820/4885 |
| US-20230310285-A1 | DEVELOPER COMPOSITION COMPRISING DIRECT DYE | TYR, CYB5R3, POLR1C | GNG2 1706/4885GNB1 2112/4885MEN1 2132/4885 |
| US-20260048025-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | SCO2, CNR2, CNR1 | GNG2 1435/4885GNB1 801/4885MEN1 1906/4885 |
| US-12281180-B2 | Peptoid-peptide macrocycles, pharmaceutical compositions and methods of using the same | WNT1, WNT3, WNT3A | GNG2 804/4885GNB1 948/4885MEN1 1000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.